Feasibility Study on LITT for Newly Diagnosed Glioblastoma

NCT02880410 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated (failure to enroll)

Conditions

Glioblastoma

Interventions

DEVICE: NeuroBlate System
DRUG: Radiation therapy and temozolomide

Sponsor

Monteris Medical